D.E. Shaw & Co’s Stoke Therapeutics STOK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $348K | Buy |
+30,696
| New | +$348K | ﹤0.01% | 2644 |
|
2025
Q1 | – | Sell |
-28,043
| Closed | -$309K | – | 3329 |
|
2024
Q4 | $309K | Sell |
28,043
-143,203
| -84% | -$1.58M | ﹤0.01% | 2586 |
|
2024
Q3 | $2.1M | Buy |
171,246
+34,236
| +25% | +$421K | ﹤0.01% | 1771 |
|
2024
Q2 | $1.85M | Sell |
137,010
-56,750
| -29% | -$767K | ﹤0.01% | 1846 |
|
2024
Q1 | $2.62M | Buy |
193,760
+51,049
| +36% | +$689K | ﹤0.01% | 1619 |
|
2023
Q4 | $751K | Sell |
142,711
-62,455
| -30% | -$329K | ﹤0.01% | 2206 |
|
2023
Q3 | $808K | Buy |
205,166
+88,701
| +76% | +$349K | ﹤0.01% | 2122 |
|
2023
Q2 | $1.24M | Buy |
116,465
+50,496
| +77% | +$537K | ﹤0.01% | 1980 |
|
2023
Q1 | $550K | Sell |
65,969
-2,866
| -4% | -$23.9K | ﹤0.01% | 2478 |
|
2022
Q4 | $635K | Buy |
68,835
+42,700
| +163% | +$394K | ﹤0.01% | 2623 |
|
2022
Q3 | $336K | Buy |
+26,135
| New | +$336K | ﹤0.01% | 3032 |
|
2022
Q1 | – | Sell |
-10,065
| Closed | -$241K | – | 4474 |
|
2021
Q4 | $241K | Buy |
+10,065
| New | +$241K | ﹤0.01% | 3410 |
|
2021
Q3 | – | Sell |
-7,143
| Closed | -$240K | – | 3838 |
|
2021
Q2 | $240K | Sell |
7,143
-4,714
| -40% | -$158K | ﹤0.01% | 3189 |
|
2021
Q1 | $461K | Buy |
+11,857
| New | +$461K | ﹤0.01% | 2524 |
|